Rare demyelinating diseases of the central nervous system - A diagnostic and therapeutic challenge. The case report of a young woman with MOGAD

Key Points

• MOGAD presents significant diagnostic challenges due to overlapping symptoms with other conditions, complicating treatment.
• Key findings show that timely identification of biomarkers can significantly aid the diagnosis and management of MOGAD.
• Observational analysis of a case report indicates a need for improved treatment protocols for rare central nervous system diseases.
• Understanding the nuances of rare demyelinating diseases supports better patient outcomes, emphasizing the importance of awareness.